Streetbeat News

Stock Prices

SPY

USO

According to sources, OPEC+ is unlikely to alter its output policy before its June meeting. This decision could impact global oil supply and prices.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:17 pm

LULU

Deep-pocketed investors show a divided sentiment towards Lululemon Athletica (NASDAQ:LULU), with equal bullish and bearish positions in the options market. Benzinga's tracking revealed 32 significant options activities, indicating a potential price movement between $365.0 and $470.0. The company, known for its athletic apparel and accessories, is currently trading at $393.02, up 1.06%, with an RSI suggesting it may be oversold. Analysts maintain positive ratings, with an average target price of $495.2.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:15 pm

EFSH

1847 Holdings LLC (EFSH) has requested the withdrawal of its Registration Statement on Form S-3, initially filed on February 1, 2023, with no shares sold under this statement. The company emphasizes its focus on building value within its portfolio, highlighting recent developments with ICU Eyewear, Signature Home Craft, and Wolo Manufacturing. These initiatives aim to enhance shareholder value and reflect the company's strategy of acquiring and improving small companies for higher valuations through sales or IPOs.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:04 pm

NEARUSD

NEAR Protocol (CRYPTO: NEAR) has seen a 4.86% increase in price over the last 24 hours, reaching $7.81. This is part of a larger trend, with a 16.0% gain over the past week from $6.79. Despite this growth, it remains below its all-time high of $20.44. The trading volume has decreased by 24.0% over the past week, while the circulating supply has slightly increased by 0.27% to 1.04 billion. NEAR's market cap ranks it 22nd at $8.07 billion.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:03 pm

SNX

TD SYNNEX shares surged following the announcement of higher-than-expected Q1 revenues and a new $2 billion share repurchase authorization.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 3:03 pm

LINKUSD

Chainlink (CRYPTO: LINK) has seen a 5.3% price increase in the last 24 hours, reaching $20.26, continuing a positive trend with a 15.0% gain over the past week from $17.51. Despite a 39.0% decrease in trading volume and a slight 0.35% drop in circulating supply to 587.10 million, LINK's market cap ranks #15 at $11.84 billion. The coin's all-time high is $52.70.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:02 pm

IVV

IYR

MBB

SCHH

SPY

VMBS

VNQ

VOO

XLRE

Greg McBride, CFA, predicts that interest rates, which rose quickly, will decrease gradually. He advises savers to seek high-return opportunities and borrowers to reduce high-cost debt. The real estate market is expected to remain a seller's market with high prices and limited inventory, positively impacting real estate ETFs. Mortgage ETFs may see mixed effects due to rising home prices. Legislative acts like the CHIPS and Infrastructure Acts suggest building a diversified portfolio, with large ETFs providing a stable investment strategy.

Portfolio Pulse from Surbhi Jain

March 26, 2024 | 3:01 pm

SHWZ

Medicine Man Technologies (OTC:SHWZ) is expected to report a quarterly EPS of $-0.13 on March 27, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's earnings performance has led to varied stock price reactions. Over the last year, SHWZ shares have declined by 22.03%, reflecting investor sentiment ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:01 pm

EAST

Eastside Distilling (NASDAQ:EAST) is scheduled to release its quarterly earnings report on March 27, 2024, with an expected EPS of $-0.90. Analysts and investors are keen on whether EAST will surpass this estimate and provide positive future guidance. Historical data shows a correlation between earnings performance and stock price movement. EAST's stock has declined 80% over the last year, trading at $1.03 as of March 25.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:01 pm

TOI

The Oncology Institute (NASDAQ:TOI) is expected to report a quarterly EPS of $-0.11 on March 27, 2024. Analysts and investors are looking for an earnings beat and positive guidance for the next quarter. Historically, TOI's stock price has shown significant movement post-earnings announcement, with a notable 27.72% increase after last quarter's miss. Over the last year, TOI shares have surged by 150.5%, indicating strong long-term shareholder satisfaction.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 3:01 pm